409 related articles for article (PubMed ID: 15781662)
1. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
Ormandy LA; Hillemann T; Wedemeyer H; Manns MP; Greten TF; Korangy F
Cancer Res; 2005 Mar; 65(6):2457-64. PubMed ID: 15781662
[TBL] [Abstract][Full Text] [Related]
2. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
3. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
4. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
[TBL] [Abstract][Full Text] [Related]
5. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
7. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study.
Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK
Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
[TBL] [Abstract][Full Text] [Related]
10. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
[TBL] [Abstract][Full Text] [Related]
12. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.
Lee WC; Wu TJ; Chou HS; Yu MC; Hsu PY; Hsu HY; Wang CC
Surgery; 2012 Feb; 151(2):213-22. PubMed ID: 21975289
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
Li L; Lao SH; Wu CY
Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Jin J; Li XY; Zhou le D; Huo Z; Zhou JH; Chen W
Digestion; 2009; 79(3):169-76. PubMed ID: 19329856
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
16. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.
Meignin V; Peffault de Latour R; Zuber J; Régnault A; Mounier N; Lemaître F; Dastot H; Itzykson R; Devergie A; Cumano A; Gluckman E; Janin A; Bandeira A; Socié G
Exp Hematol; 2005 Aug; 33(8):894-900. PubMed ID: 16038781
[TBL] [Abstract][Full Text] [Related]
17. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis.
Möttönen M; Heikkinen J; Mustonen L; Isomäki P; Luukkainen R; Lassila O
Clin Exp Immunol; 2005 May; 140(2):360-7. PubMed ID: 15807863
[TBL] [Abstract][Full Text] [Related]
18. CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma.
Nakao M; Sata M; Saitsu H; Yutani S; Kawamoto M; Kojiro M; Itoh K
Cell Immunol; 1997 May; 177(2):176-81. PubMed ID: 9178645
[TBL] [Abstract][Full Text] [Related]
19. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
Yang XH; Liu BR; Jiang HC
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
[TBL] [Abstract][Full Text] [Related]
20. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.
Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S
Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
